高榕创投

高榕创投

@gaorong

创造美好生活

531 articles

Articles

Inno Pharmaceuticals Completes Nearly RMB 800 Million Series D Funding to Accelerate Global Multicenter Clinical Development of Precision Targeted Drugs

Inno Pharmaceuticals Completes Nearly RMB 800 Million Series D Funding to Accelerate Global Multicenter Clinical Development of Precision Targeted Drugs

The company has pioneered a proprietary active-targeting liposomal drug delivery platform, underpinning an innovative drug pipeline that spans multiple serious disease areas, including cardiovascular and cerebrovascular diseases and glioblastoma.

Gaorong Ventures Report: Physical AI, Domestic Computing Power, Controllable Nuclear Fusion, and Medical Innovation Companies Close Major Funding Rounds

Gaorong Ventures Report: Physical AI, Domestic Computing Power, Controllable Nuclear Fusion, and Medical Innovation Companies Close Major Funding Rounds

From the continuous leap in model capabilities to hard tech crossing the thresholds of engineering and industrialization, a new wave of technological innovation is accelerating toward the real world.